The loophole to get Hims prescription hair loss treatment for $1
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our…
Here’s What Experts Say You Need If You’re On A GLP-1
It’s no secret that the use of GLP-1 antagonists like Ozempic and Wegovy is more widespread than ever.…
People taking GLP-1 medications report fingernail loss in new study
NEWYou can now listen to Fox News articles! People taking GLP-1 medications for obesity or diabetes experience nail…
GLP-1 Users Report More Nail Detachments
GLP-1 drugs may be doing more than shrinking waistlines. An early international survey presented at a major…
I’m a dermatologist — the top 10 things I tell balding patients
Don’t brush off this information. More than 80% of men and women experience some pattern hair loss during…
Why everyone’s turning to minoxidil for hair growth
Hair loss, be it seasonal shedding, postpartum hair loss or androgenetic alopecia, is incredibly discouraging, which may explain…
No, creatine won’t make you go bald
Creatine has become one of the most widely used supplements on the market, but a rumour that has…
11 topical minoxidil alternatives to boost hair growth
For years, topical minoxidil has been the gold-standard treatment for hair growth. So, it’s no surprise that its…
New Baldness Pill Boosts Hair Coverage by Up to 86% in Six Months
AI-generated image. A familiar hair-loss drug may be getting a major upgrade. A slow-release formulation of minoxidil, one…
Mallia Aesthetics Reports Positive Results from Consumer
87% of participants responded to treatment, with 70% showing new hair growthAverage hair density increased significantly by 30%,…
Should you be mineral balancing? How it can improve stress, sleep
Don’t take minerals for granite. Sodium, calcium, potassium and magnesium regulate hydration, manage nervous system function, support metabolism…
Veradermics hair loss pill passes late-stage clinical trial
Veradermics announced Monday that its experimental oral hair loss pill, VDPHL01, met all primary and key secondary endpoints…